Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Nechaeva, Marina"'
Autor:
Baramidze A; Todua Clinic, Tbilisi, Georgia. Electronic address: baramidzeana@gmail.com., Makharadze T; LTD High Technology Hospital Med Center, Batumi, Georgia., Gogishvili M; High Technology Medical Centre, University Clinic Ltd, Tbilisi, Georgia., Melkadze T; Todua Clinic, Tbilisi, Georgia., Giorgadze D; Multiprofilie Clinic Consilium Medulla, Tbilisi, Georgia., Penkov K; Private Medical Institution Euromedservice, Saint Petersburg, Russia., Laktionov K; Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology' of the Ministry of Health of the Russian Federation, Moscow, Russia., Nemsadze G; The Institute of Clinical Oncology, Tbilisi, Georgia., Nechaeva M; Chelyabinsk Regional Clinical Oncology Center, Chelyabinsk, Russia., Rozhkova I; Kaluga Regional Clinical Oncology Dispensary, Kaluga, Russia., Kalinka E; Polish Mother's Memorial Hospital Research Institute, Łódź, Poland., Ag McIntyre D; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Perez J; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Kaul M; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Quek RGW; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Seebach F; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Rietschel P; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Pouliot JF; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
Publikováno v:
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2024 Jul; Vol. 193, pp. 107821. Date of Electronic Publication: 2024 May 13.
Autor:
Moehler M; Department of Internal Medicine, Johannes-Gutenberg University, Mainz, Germany., Dvorkin M; Department of Oncology, Budgetary Healthcare Institution of Omsk Region Clinical Oncology Dispensary, Omsk, Russian Federation., Boku N; National Cancer Center Hospital, Tokyo, Japan., Özgüroğlu M; Clinical Trial Unit, Division of Medical Oncology, Department of Internal Medicine, Cerrahpaşa Medical Faculty, Istanbul University-Cerrahpaşa, Istanbul, Turkey., Ryu MH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Muntean AS; Department of Research, Oncology Institute Prof Dr Ion Chiricuţă, Cluj Napoca, Romania., Lonardi S; Dipartimento di Oncologia Clinica e Sperimentale, Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padova, Italy., Nechaeva M; Arkhangelsk Clinical Oncological Dispensary, State Budgetary Healthcare Institution of Arkhangelsk Region, Arkhangelsk, Russian Federation., Bragagnoli AC; Hospital de Câncer de Barretos-Fundação Pio XII, São Paulo, Brazil., Coşkun HS; Department of Medical Oncology, Akdeniz University Medical Faculty, Antalya, Turkey., Cubillo Gracian A; Hospital Universitario HM Sanchinarro, Madrid, Spain.; CEU Universidad San Pablo, Madrid, Spain., Takano T; Toranomon Hospital, Tokyo, Japan., Wong R; Eastern Health, Box Hill Hospital, Monash University, Melbourne, Victoria, Australia., Safran H; Rhode Island Hospital, Brown University, Providence, RI., Vaccaro GM; Oregon Health & Science University, Portland, OR., Wainberg ZA; Ronald Reagan University of California Los Angeles Medical Center, Santa Monica, CA., Silver MR; EMD Serono Research & Development Institute, Inc, Billerica, MA; an affiliate of Merck KGaA, Darmstadt, Germany., Xiong H; EMD Serono Research & Development Institute, Inc, Billerica, MA; an affiliate of Merck KGaA, Darmstadt, Germany., Hong J; EMD Serono Research & Development Institute, Inc, Billerica, MA; an affiliate of Merck KGaA, Darmstadt, Germany., Taieb J; Department of Gastroenterology and Digestive Oncology, Georges-Pompidou European Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris, Paris, France., Bang YJ; Seoul National University Hospital, Seoul, Republic of Korea.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Mar 20; Vol. 39 (9), pp. 966-977. Date of Electronic Publication: 2020 Nov 16.
Autor:
Gorbunova V; N.N. Blokhin Russian Cancer Research Center, Moscow, Russia., Beck JT; Highlands Oncology, Rogers/Fayetteville, AR, USA., Hofheinz RD; Interdisciplinary Tumor Center, University Hospital Mannheim, University of Heidelberg, Heidelberg, Germany., Garcia-Alfonso P; Hospital General Universitario Gregorio Marañón, Madrid, Spain., Nechaeva M; Arkhangelsk Clinical Oncology Center, Arkhangelsk, Russia., Cubillo Gracian A; Centro Integral Oncológico Clara Campal Hospital Universitario Madrid Sanchinarro, Madrid, Spain, and Departamento de Ciencias Médicas Clínicas, Universidad CEU San Pablo, Madrid, Spain., Mangel L; Pecsi Tudomanyegyetem Klinikai Kozpont, Onkoterapias Intezet, Pécs, Hungary., Elez Fernandez E; Vall d'Hebron University Hospital, Barcelona, Spain., Deming DA; University of Wisconsin, Madison, WI, USA., Ramanathan RK; Mayo Clinic, Scottsdale, AZ, USA., Torres AH; AbbVie Inc., North Chicago, IL, USA., Sullivan D; AbbVie Inc., North Chicago, IL, USA., Luo Y; AbbVie Inc., North Chicago, IL, USA., Berlin JD; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. jordan.berlin@vumc.org.
Publikováno v:
British journal of cancer [Br J Cancer] 2019 Jan; Vol. 120 (2), pp. 183-189. Date of Electronic Publication: 2018 Dec 11.